A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : KSHV / KS-associated herpesvirus

[Related PubMed/MEDLINE]
Total Number of Papers: 69
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   KSHV  (>> Co-occurring Abbreviation)
Long Form:   KS-associated herpesvirus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82. CAM, KS, Lef1, vIRF1
2020 DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma. KS, scFv, VEGF-A
2019 KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. IL-6, KS, VL
2019 PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment. KS
2019 Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-kappaB activation, and promotion of cell invasion and angiogenesis. KS, vFLIP
2018 Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. ECs, KS, MCs
2017 A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling. CD82, KS, miR-K6, miRNAs, SH3BGR
2017 Diagnosis and Treatment of Kaposi Sarcoma. KS, LANA
2016 c-Myc and viral cofactor Kaposin B co-operate to elicit angiogenesis through modulating miRNome traits of endothelial cells. angiomiRs, KS, miRNAs, smRNA-seq
10  2016 Recapitulation of acquired immuno deficiency syndrome associated Kaposi's sarcoma. AIDS, HIV, KS
11  2016 Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study. KS, NK, ORs
12  2015 Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression. CDK1, KS
13  2014 Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene. 4EBP, eIF4E, KS, vGPCR
14  2014 HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway. KS
15  2014 Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. HDAC, KS
16  2014 Viral profiling identifies multiple subtypes of Kaposi's sarcoma. ART, IQR, KS, miRNAs, qPCR
17  2013 Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria. KS
18  2013 Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era. CT, HAART, HHV-8, HIV, KS
19  2013 Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. HAART, KS, miRNAs, PEL
20  2013 Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. KS, MZ
21  2012 Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. Gal-1, HIF, KS
22  2012 Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. Hsp90, KS, LANA
23  2012 Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. KS
24  2011 Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls. CKS, DTH, KS
25  2011 Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. CI, DTH, EBV, KS, LANA, OR
26  2011 Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. HIV-1, KS
27  2011 The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation. KS
28  2010 Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. KS
29  2010 Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. cART, HR, IRIS-KS
30  2010 Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. CI, KS
31  2010 Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. CKS, sCD
32  2009 Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. 5-dFUrd, 5-FU, IKK, KS
33  2009 Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. CKS, KS
34  2008 Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. KS, PI3K, VEGFR-3
35  2008 Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin. KS, VE-cadherin
36  2006 Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. KS
37  2006 Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. CKS, EBV, LANA, OR, PBMC
38  2005 Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. ITAM, KS, SH2
39  2005 Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma. KS, PCR
40  2005 Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment. KS
41  2005 KSHV/HHV-8 associated Kaposi's sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphoma. HHV-8, HL, KS, RS
42  2005 T-cell transformation and oncogenesis by gamma2-herpesviruses. HHV-8, HVA, HVS, KS, PEL
43  2004 HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. KS
44  2004 Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. KS
45  2003 Pathogenesis of Kaposi's sarcoma. KS
46  2002 Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy. HAART, HIV-1, KS, SFC
47  2002 Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City. KS
48  2002 Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. DMVEC, KS, SCF
49  2002 Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. KS
50  2002 Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma. KS
51  2002 Risk factors for classical Kaposi's sarcoma. CIs, KS, ORs
52  2001 Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. DMVEC, KS, PEL
53  2000 Classic kaposi sarcoma: epidemiology and risk factors. HHV-8, HIV, KS
54  2000 Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. KS
55  1999 Absence of Kaposi's sarcoma-associated herpesvirus DNA in bacillary angiomatosis-peliosis lesions. BA, BP, KS
56  1998 Epidemic Kaposi's sarcoma. HIV-1, KS
57  1997 High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda. KS, PBMC
58  1997 Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. KS
59  1997 Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology. HHV-8, KS
60  1997 Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. AIDS, HIV, KS
61  1996 Herpesvirus-like DNA Sequences in Japanese Patients with AIDS-related Kaposi's Sarcoma. KS
62  1996 Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. AIDS, KS
63  1996 Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumors. HHV-8, KS
64  1996 Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. KS
65  1996 Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. HHV-8, KS
66  1996 Pathogenesis of oral Kaposi's Sarcoma in HIV-infection: relevance of endogenous glucocorticoid excess in blood and saliva. KS
67  1996 Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide. KS
68  1996 Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. HHV-8, KS
69  1994 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. AIDS, KS